Retinamidic acid

4‑((15‑Oxoretin‑15‑yl)amino)benzoic acid, also known as Retinamidic acid, is a retinoid derivative. It has no officially approved medical uses but appears in patent literature for potential skin-whitening and tyrosinase inhibition. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include N-(4-Carboxyphenyl)retinamide, (BENZOIC ACID, 4-((15-OXORETIN-15-YL)AMINO)-) and QGJ09HO5S0. Its PubChem CID is 6505394.

CAS No 74193-17-2
Molecular Formula C27H33NO3
Molecular Weight 419.6 g/mol
Synonyms 4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoic acid

Frequently Asked Questions